Indolyl derivatives as liver-X-receptor (LXR) modulators
US7485652B2 · kind B2 · utility
1Cited by
1References
2Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 11, 2006 |
| Grant date | Feb 3, 2009 |
| Priority date | — |
| Expiry date | Dec 11, 2026 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to compounds of formula (I):and pharmaceutically acceptable salts and pharmaceutically acceptable esters thereof, wherein R1, R2, R3, R4, R5, R6, A, m, n and p are defined as in claim 1. These compounds can be used as pharmaceutical compositions for the treatment of, for example, diabetes.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.